Call Options

12 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $50.4 Million - $58.9 Million
-325,800 Reduced 44.16%
412,000 $70.7 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $21.8 Million - $24.9 Million
-136,600 Reduced 15.62%
737,800 $134 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $15.9 Million - $17.9 Million
115,800 Added 15.26%
874,400 $136 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $67.2 Million - $83.6 Million
-507,200 Reduced 40.07%
758,600 $102 Million
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $86.6 Million - $99.7 Million
598,900 Added 89.8%
1,265,800 $202 Million
Q4 2022

Feb 10, 2023

BUY
$138.31 - $165.87 $31 Million - $37.2 Million
224,100 Added 50.61%
666,900 $108 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $8.03 Million - $9.21 Million
-59,800 Reduced 11.9%
442,800 $59.4 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $5.26 Million - $6.68 Million
-38,200 Reduced 7.06%
502,600 $77 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $27.9 Million - $34.7 Million
-211,700 Reduced 28.13%
540,800 $87.7 Million
Q4 2021

Feb 08, 2022

BUY
$107.43 - $135.93 $46.7 Million - $59.1 Million
434,800 Added 136.86%
752,500 $102 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $33.8 Million - $38.3 Million
-317,400 Reduced 49.98%
317,700 $34.3 Million
Q2 2021

Sep 13, 2021

BUY
$105.21 - $117.21 $66.8 Million - $74.4 Million
635,100 New
635,100 $71.5 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.